Company News

Selexis names Yemi Onakunle as vp of strategic and market development Former Diosynth and Lonza executive joins Swiss life science company Baltimore Innovations appoints Matthew Valentine as md Founder Ted Valentine becomes chairman Almac appoints new financial director Promotes Kevin Stephens to the role Thermo Fisher awards Oxoid Prize for microbiology Young scientist receives recognition for studies on antibiotic synergy Baxter appoints Jean-Luc Butel as president, international He takes up the role on 20 February Teva announces management succession Jeremy Levin to become ceo of Teva in May and Rob Koremans will become ceo of Teva Europe in March Helix BioPharma makes two appointments Jack Kay as chairman and Professor Kazimierz Roszkowski-Sliz as European Medical Director Marken names vp of Global Quality Assurance Steve Roese takes up the role Inovio Pharmaceuticals promotes Niranjan Sardesai From senior vp of r&d to chief operating officer Takeda makes two promotions Ken Araki and Kouji Iwasaki take up their new roles on 1 January DaVita Labs appoints vp and general manager Chronic kidney disease laboratory hires Leslie Mirani Key Technology makes a promotion Bret Larreau becomes manager of business development Aesica appoints new site manager at Cramlington David Leaver is promoted from operations manager AndersonBrecon Clinical Services hires Nick Evans Joins the Hay-on-Wye firm as business development manager Bio-Images Research appoints director of regulatory affairs To maintain highest level of ethical standards as firm expands GenVec president and ceo to retire US firm hires recruitment firm to find a successor

Trending Articles

  1. New Managing Director for Shimadzu Europa Dr. Florian Geistmann (pictured) takes over as Managing Director of Shimadzu Europa, succeeding Jürgen Semmler, who has retired after five years at the helm of the European organisation and more than 39 years in the company in total
  2. BioDuro appoints Greg Makara to lead discovery chemistry BioDuro has appointed Greg Makara, PhD, as Senior Vice President, Lead Discovery Chemistry, as the contract research, development and manufacturing organisation (CRDMO) looks to strengthen its early-stage drug discovery capabilities.
  3. EyeC expands OEM growth with new business development manager Rigel Gallegos will lead the development of EyeC’s OEM and system integrator business
  4. Three new commercial appointments for Symbiosis Symbiosis Pharmaceutical Services has expanded its commercial team with three new appointments as the specialist aseptic fill-finish CDMO targets further growth across Asia-Pacific, the Middle East and Southern Europe
  5. Lonza nominates Pearl Huang to board Lonza has nominated Pearl Huang as an independent member of its Board of Directors, bringing extensive pharmaceutical and biotechnology experience and expertise in drug discovery and innovation